11 results on '"Mahashabde R"'
Search Results
2. PCN210 MEDICAL CARE ACCESS AND COSTS AMONG CANCER SURVIVORS ENROLLED IN A HIGH DEDUCTIBLE HEALTH PLAN
- Author
-
Mahashabde, R., primary and Li, C., additional
- Published
- 2020
- Full Text
- View/download PDF
Catalog
3. Emergency Room Visits and Out of Pocket Expenditure Among Individuals Enrolled in a High Deductible Health Plan
- Author
-
Mahashabde, R, primary and Vaidya, V, additional
- Published
- 2018
- Full Text
- View/download PDF
4. PHS105 - Emergency Room Visits and Out of Pocket Expenditure Among Individuals Enrolled in a High Deductible Health Plan
- Author
-
Mahashabde, R and Vaidya, V
- Published
- 2018
- Full Text
- View/download PDF
5. Antimicrobial Activity and HPLC Fingerprinting of CrudeOcimumExtracts
- Author
-
Deo, S. S., primary, Inam, F., additional, and Mahashabde, R. P., additional
- Published
- 2011
- Full Text
- View/download PDF
6. Antimicrobial Activity and HPLC Fingerprinting of Crude Ocimum Extracts
- Author
-
S. Deo, S., Inam, F., and P. Mahashabde, R.
- Abstract
The antimicrobial activity of crude methanolic and aqueous extracts of Ocimum sanctum and Ocimum kilimandsacharicum against gram positive, gram negative and antifungal activity was evaluated to find the zone of inhibition and to set a HPLC profile or fingerprint of these extracts. The crude methanolic extract of Ocimum sanctum showed strong antimicrobial activity against S.aureus and C. albicans and moderate activity against E. coli and B. subtilis. The crude methanolic extract of Ocimum kilimandsacharicum showed strong antimicrobial activity against S. aureus, E. coli and C. albicans at higher concentration, same as that shown by the standard for C. albicans. It showed moderate activity against B. subtilis. The crude aqueous extracts of Ocimum sanctum showed strong antimicrobial activity against S.aureus and moderate against others. Whereas the crude aqueous extracts of Ocimum kilimandsacharicum showed moderate activity against the gram positive and gram negative organisms and strong activity against C. albicans at higher concentration, same as that shown by the standard for C. albicans. more...
- Published
- 2011
- Full Text
- View/download PDF
7. Assessment of Metformin Intolerance: A Retrospective Chart Review.
- Author
-
Murphy PZ, Bramwell-Shittu A, Boehmer K, Painter J, and Mahashabde R
- Abstract
Objective: The aim of the present study is to determine similarities between patients with type 2 diabetes not on metformin therapy compared to patients on metformin therapy at a resident-led primary care clinic. Methods: An exploratory, single-center retrospective chart review was performed on patients 18 years and older with a documented diagnosis of type 2 diabetes seen at the University of Arkansas for Medical Sciences Family Medicine Clinic in Little Rock, Arkansas. Of the 2452 patients who met criteria for the study, 1085 patients did not have a documented metformin allergy. A subset of 216 patients who were not currently prescribed metformin and had no documented metformin allergy were further examined and compared to the 869 patients who were prescribed metformin. We sought to determine reasons for nonuse by evaluating their EPIC electronic health record. Information on these patients such as race, gender, hemoglobin A1c (A1c), kidney function, stated metformin intolerance, and comorbid disease states such as neuropathy, chronic kidney disease (CKD), ulcerative colitis, and irritable bowel syndrome were collected. Further examination was performed to determine why patients were not on metformin therapy and potential similarities between metformin intolerant patients. Results: The results of the study indicated a significant difference between metformin users and non-users in relation to body mass index (BMI) and diagnosis of CKD. Metformin non-users were found to have significantly lower mean BMI (30.87 vs. 35.43; p-value <0.0001), and significantly higher rates of CKD (25.93% vs 14.73%; p-value <0.0001) as compared to metformin users. BMI value of patients (coefficient: 0.2033, p value: <0.0001) was found to be significantly and positively correlated with metformin use, and CKD (coefficient: - 0.1191, p-value: <0.0001) was found to be significantly and negatively correlated with metformin use. A1c levels for patients not on metformin therapy were evaluated. Most non-metformin patients fell in prediabetic A1c levels ranging from 5-6.4% (84 patients; 38.89%), and 31 patients (14.35%) should be on insulin therapy according to guidelines. Conclusion: The results demonstrated that patients with lower BMI, CKD, or A1c in the prediabetic range were less likely to be prescribed metformin., (© Individual authors.) more...
- Published
- 2024
- Full Text
- View/download PDF
8. Understanding and Managing Metabolic Deficiencies Post Bariatric and Esophagectomy Surgeries: A Narrative Review of the Literature.
- Author
-
Daniel M, Al Dhib R, Mendoza M, Tisekar SN, Cingireddy AR, Essani B, Mahashabde R, Maddineni SA, and Kamel M
- Abstract
Gastrectomy and esophagectomy are the most performed surgeries in the treatment of both esophageal and gastric cancers. The type of esophagectomy depends on the type of malignancy, site of the tumor, criteria of resection, and field of resection. The three standard approaches to esophagectomy are the transhiatal approach, the left thoracoabdominal approach, and a three-stage procedure. The transhiatal approach involves abdominal and cervical incisions, while the left thoracoabdominal approach is a one-stage procedure that utilizes a single incision exposing the dissection field. The Ivor Lewis and McKeown esophagectomies are two-stage and three-stage surgeries that include laparotomy with right thoracotomy. Malabsorption often emerges as a significant postoperative complication following esophagectomy and gastrectomy surgeries. Malnutrition linked with these cancers has detrimental effects, including heightened rates of postoperative complications, elevated infection risks, delayed wound healing, reduced tolerance to treatment, diminished quality of life, and heightened mortality rates. Our narrative review summarizes and sheds light on solutions to treat malabsorption disorders and malnutrition after gastric bypass surgery. These solutions include methods such as adjustments, supplements, and treatment. Although more research is needed to confirm their effectiveness, these methods indicate potential for lowering the impact on patients' diets. By considering the beneficial implications of these effects and considering solutions, we aim to improve the management of these adverse effects, ultimately improving the overall health and postoperative outcomes of patients., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Daniel et al.) more...
- Published
- 2024
- Full Text
- View/download PDF
9. Nonelderly Adult Cancer Survivors in High Deductible Health Plan: Healthcare Expenditure, Utilization and Access.
- Author
-
Mahashabde R and Li C
- Abstract
Background : To compare healthcare expenditure, utilization and access between nonelderly adult cancer survivors enrolled in a high deductible health plan with a health savings account ("HDHP+HSA"), HDHP without HSA ("HDHP alone") and low deductible health plan ("LDHP"). Methods : 1735 cancer survivors, aged 18-64 years, with continuous private coverage identified from the 2012-2017 Medical Expenditure Panel Survey: HDHP alone (n = 353), HDHP+HSA (n = 242) and LDHP (n = 1140). Healthcare expenditures, utilization and inability/delay obtaining medical care were analyzed using generalized linear regressions with inverse propensity score weighting and doubly robust estimation. Results : HDHP alone group (23,255 USD) had significantly higher total healthcare expenditure compared to HDHP+HSA (15,580 USD, p = 0.012) and LDHP (16,261 USD, p = 0.016). HDHP alone (6089 USD; p = 0.002) and HDHP+HSA (5743 USD; p = 0.012) groups had significantly higher out-of-pocket (OOP) expenditure compared to LDHP (4853 USD). HDHP alone (17,128 USD, p = 0.010) and LDHP (12,645 USD, p = 0.045) had significantly higher private insurer payments compared to HDHP+HSA (9216 USD). No differences were found in utilization or inability/delay obtaining medical care across groups. Conclusions : Non-elderly adult cancer survivors with continuous coverage and comparable sociodemographic characteristics enrolled in HDHP with HSA displayed the lowest healthcare costs compared to HDHP without HSA and LDHP. HDHP+HSA had a significantly higher OOP expenditure than LDHP. No significant differences were observed in utilization or access among groups. more...
- Published
- 2021
- Full Text
- View/download PDF
10. A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018.
- Author
-
Dandu V, Siddamreddy S, Thombre V, Veerapaneni KD, Yadala S, Sheng S, Mahashabde R, Harada Y, Kapoor N, Onteddu S, and Nalleballe K
- Abstract
Background and objectives Sleep medicine has been one of the fastest-growing medical fields in recent years. The industry plays a big role in developing new medications and devices for both diagnosis and treatment of sleep-related problems. We analyzed payments made by industry to physicians from 2014 through 2018 based on the Open Payments Program data. Methods Centers for Medicare and Medicaid Services Open Payment Program and American Board of Psychiatry and Neurology databases were explored to elicit financial relationships between industry and sleep neurologists. Results Payments made by industry to sleep neurologists have been steadily increasing from 2014 through 2018. Approximately 16% to 22% of sleep certified neurologists received payments from industry during the study period. Interestingly, the payments made to the top 10% of the sleep physicians contributed approximately 85% to 96% of the total payments. The top two categories to which the highest payments were made were compensation for services and royalty and/or licensing fees. Silenor® (doxepin), Xyrem® (sodium oxybate), Aptiom® (eslicarbazepine acetate), Belsomra® (suvorexant), and Fycompa® (perampanel) were most of the drugs, which made the highest payments, that got approved by the Food and Drug Administration in the last decade. Conclusions It seems that the industry is spending significant amounts of money in educating the physicians and in marketing the newer drugs. This analysis of the data on payments from industry is very useful in identifying any potential conflicts of interest from physicians. Further analyses are needed to study the trends of physician practice behavior and decision making., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2020, Dandu et al.) more...
- Published
- 2020
- Full Text
- View/download PDF
11. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
- Author
-
Nalleballe K, Sheng S, Li C, Mahashabde R, Annapureddy AR, Mudassar K, Pothineni K, Veerapaneni P, Harada Y, Chilkulwar A, Ranabothu S, Brown A, Kapoor N, and Onteddu S
- Subjects
- Cardiology legislation & jurisprudence, Centers for Medicare and Medicaid Services, U.S. economics, Centers for Medicare and Medicaid Services, U.S. legislation & jurisprudence, Centers for Medicare and Medicaid Services, U.S. trends, Conflict of Interest legislation & jurisprudence, Databases, Factual trends, Drug Industry economics, Drug Industry legislation & jurisprudence, Drug Industry trends, Health Care Sector economics, Health Care Sector legislation & jurisprudence, Health Care Sector trends, Humans, Neurologists legislation & jurisprudence, Time Factors, United States, Cardiology economics, Cardiology trends, Conflict of Interest economics, Neurologists economics, Neurologists trends
- Abstract
Background and Purpose- Industry payments to physicians raise concerns regarding conflicts of interest that could impact patient care. We explored nonresearch and nonownership payments from industry to vascular neurologists to identify trends in compensation. Methods- Using Centers for Medicare and Medicaid Services and American Board of Psychiatry and Neurology data, we explored financial relationships between industry and US vascular neurologists from 2013 to 2018. We analyzed payment characteristics, including payment categories, payment distribution among physicians, regional trends, and biomedical manufacturers. Furthermore, we analyzed the top 1% (by compensation) of vascular neurologists with detailed payment categories, their position, and their contribution to stroke guidelines. Results- The number of board certified vascular neurologist increased from 1169 in 2013 to 1746 in 2018. The total payments to vascular neurologist increased from $99 749 in 2013 to $1 032 302 in 2018. During the study period, 16% to 17% of vascular neurologists received industry payments. Total payments from industry and mean physician payments increased yearly over this period, with consulting fee (31.1%) and compensation for services other than consulting (30.7%) being the highest paid categories. The top 10 manufacturers made the majority of the payments, and the top 10 products changed from drug or biological products to devices. Physicians from south region of the United States received the highest total payment (38.72%), which steadily increased. Payments to top 1% vascular neurologists increased from 64% to 79% over the period as payments became less evenly distributed. Among the top 1%, 42% specialized in neuro intervention, 11% contributed to American Heart Association/American Stroke Association guidelines, and around 75% were key leaders in the field. Conclusions- A small proportion of US vascular neurologists consistently received the majority of industry payments, the value of which grew over the study period. Only 11% of the top 1% receiving industry payments have authored American Heart Association/American Stroke Association guidelines, but ≈75% seem to be key leaders in the field. Whether this influences clinical practice and behavior requires further investigation. more...
- Published
- 2020
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.